An RNAi screen conducted in primary AML cells reported that SNX27 promotes AML tumorigenesis and may serve as a potential prognostic marker, since a lack of SNX27 dramatically reduces tumor cell growth and viability [130]. This evidence concerns the gene SNX27 and acute myeloid leukemia.